DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 348,300 shares, an increase of 14.0% from the March 31st total of 305,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently […]
DiaSorin (OTCMKTS:DSRLF – Get Rating) and Bankinter (OTCMKTS:BKNIY – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings. Profitability This table compares DiaSorin and Bankinter’s net margins, return on equity […]
Kepler Capital Markets downgraded shares of DiaSorin (OTCMKTS:DSRLF – Get Rating) from a hold rating to a reduce rating in a research report report published on Monday morning, Briefing.com reports. A number of other brokerages have also recently commented on DSRLF. BNP Paribas cut DiaSorin from a neutral rating to an underperform rating in a […]
/PRNewswire/ The infectious disease market size is forecasted to increase by USD 104.81 billion from 2022 to 2027, at a CAGR of 12.49%, according to the.
DiaSorin Spa reported Friday that Matteo Cirla, related to acting auditor Ottavia Alfano, purchased 1,500 ordinary shares in the company. The shares were taken over at an average price of EUR98.00. | March 31, 2023